$HQL insiders have traded $HQL stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales. Here’s a ...
$HQL insiders have traded $HQL stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales. Here’s a ...
HQL focuses on the life sciences industry with a 74% allocation to biotechnology stocks. It pays a 2% quarterly managed distribution. The boom-bust nature of biotech stocks may not be suitable for a ...
Get complete details on the Abrdn Life Sciences Investors stock dividend, including HQL dividend history and HQL dividend yield. Find the latest HQL dividend date, ex-dividend date, and dividend ...
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2024 / abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, ...
abrdn Life Sciences Investors Fund maintains a buy rating, offering a compelling 11.6% yield and trading at a 9.58% NAV discount. HQL’s income-focused strategy relies on net realized gains, supporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results